Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02009644 · ClinicalTrials.gov registry record · NA
Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic Aneurysms
A NA study of Abdominal Aortic Aneurysm (AAA), sponsored by Bolton Medical.
- Active
- Registry status
- NA
- Development phase
- 158
- Enrollment target
- 20
- Study locations
NCT02009644: Active NA study of Abdominal Aortic Aneurysm (AAA), sponsored by Bolton Medical.
NCT02009644 is a NA study of Abdominal Aortic Aneurysm (AAA) that is active but no longer recruiting, run by Bolton Medical. The registered enrollment target is 158 participants, above the 136-participant average among 3 other Abdominal Aortic Aneurysm (AAA) trials with a reported enrollment target (16% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02009644, a NA study of Abdominal Aortic Aneurysm (AAA), is active but no longer recruiting, sponsored by Bolton Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this clinical trial is to assess and evaluate the safety and efficacy of the Treovance Stent-Graft with Navitel Delivery System in subjects with Abdominal Aortic Aneurysms (AAA).
Primary Outcome
Successful aneurysm treatment which is a composite of the following: Technical success at the conclusion of the procedure; absence of aneurysm enlargement; absence of device-related complications (e.g., fracture, conversion to open surgical repair, etc.)
Conditions Studied
Interventions
- DEVICE Subjects who receive the Treovance stent-graft
Study Locations (20)
New York
- Community Care (previously Albany Medical Center) - Albany
- Buffalo General Medical Center - Buffalo
- Mount Sinai Medical Center - New York
- University of Rochester -- Strong Memorial Hospital - Rochester
- Stony Brook Medical Center - Stony Brook
Illinois
- Presence Medical Center -- Christie Clinic - Champaign
- University of Chicago - Chicago
- Affiliated Surgeons of Rockford Memorial Hospital - Rockford
Massachusetts
- Tufts University Medical Center - Boston
- Massachusetts General Hospital - Boston
- University of Massachusetts - Worcester
North Carolina
- Mission Hospital - Asheville
- East Carolina University / Pitt County Memorial Hospital - Greenville
Alabama
- University of Alabama-Birmingham - Birmingham
Arizona
- Arizona Heart Institute - Phoenix
Connecticut
- Danbury Hospital - Danbury
Florida
- Lynn Heart and Vascular Institute - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2013-11-23 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT02009644 still lists
NCT02009644 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, above the 136-participant average among 3 other Abdominal Aortic Aneurysm (AAA) trials with a reported enrollment target (16% higher).
The record links to 1 condition, with Abdominal Aortic Aneurysm (AAA) appearing as the primary indexed condition, and to 1 intervention - of which Subjects who receive the Treovance stent-graft is the first listed.
NCT02009644 names 20 study sites across 11 states, led by New York, Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02009644 about?
NCT02009644 is a clinical study titled "Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic Aneurysms". The purpose of this clinical trial is to assess and evaluate the safety and efficacy of the Treovance Stent-Graft with Navitel Delivery System in subjects with Abdominal Aortic Aneurysms (AAA).
What is the current status of trial NCT02009644?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 158 participants. The study started on 2013-11-23. Estimated completion is 2026-06.
What conditions does trial NCT02009644 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm (AAA).
What interventions are being tested in trial NCT02009644?
The interventions under investigation include: Subjects who receive the Treovance stent-graft (DEVICE).
Who is sponsoring clinical trial NCT02009644?
This trial is sponsored by Bolton Medical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02009644 being conducted?
This trial has 20 study locations across Alabama, Arizona, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm (AAA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI